Empagliflozin Reduces Risk for Nephropathy Regardless of Blood Pressure, LDL Cholesterol, HbA1c
Investigators examined renal outcomes when controlling cardiovascular risk factors, such as blood pressure, LDL-C, and HbA1c.
Diagnosis & Disease Information
Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
Investigators analyzed real world data to examine the risk for below-knee amputations in patients with type 2 diabetes taking canagliflozin vs other medications.
Beta-Blockers Show Varied Effects on Hypoglycemic Mortality Risk in Diabetes
Investigators examined the relationship between the use of β-blockers and incidence of hypoglycemia and risk for mortality in hospitalized patients with diabetes.
Pen vs Patch Bolus Insulin Delivery for T2D Using CGM
Investigators compared 2 methods of delivering bolus insulin, pen vs patch, using metrics from continuous glucose monitoring.
Metabolic Health Predicative of Cognitive Development in Children
Researchers assessed whether current metabolic parameters are inversely associated with cognitive functioning.
Liraglutide May Prevent Dementia in Elderly With Type 2 Diabetes
Investigators examined the efficacy of liraglutide for the prevention of dementia in elderly patients with type 2 diabetes.
Age, Baseline HbA1c May Predict Glycemic Control in Newly Diagnosed Type 2 Diabetes
Investigators examined the effectiveness of oral agents vs insulin as an initial treatment option for people newly diagnosed with type 2 diabetes.
Elevated Triglycerides, Diabetes May Be Predictors of Major Cardiovascular Events
Investigators examined cardiovascular outcomes in patients with elevated triglyceridemia and diabetes treated with statins.
Safety and Performance of Omnipod HCL for Children With Type 1 Diabetes
In children with type 1 diabetes, the Omnipod hybrid closed-loop personal model system was safe and performed well.
ITCA 650 Shows Efficacy in Reducing Weight, HbA1c in Type 2 Diabetes
The ITCA 650, a small titanium osmotic mini-pump, provides a subcutaneous infusion of exenatide over 3 or 6 months.
- Loading...
Loading...
Next post in ADA 78th Scientific Sessions 2018
Loading... 
Loading...